ASKA Pharmaceutical HoldingsLtd (4886) Stock Overview
Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
4886 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ASKA Pharmaceutical Holdings Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,134.00 |
| 52 Week High | JP¥2,942.00 |
| 52 Week Low | JP¥1,825.00 |
| Beta | 0.16 |
| 1 Month Change | 4.56% |
| 3 Month Change | 0.90% |
| 1 Year Change | 11.03% |
| 3 Year Change | 71.96% |
| 5 Year Change | 39.20% |
| Change since IPO | 1.62% |
Recent News & Updates
Recent updates
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 20
ASKA Pharmaceutical HoldingsLtd (TSE:4886) Is Due To Pay A Dividend Of ¥27.00
Jul 24ASKA Pharmaceutical HoldingsLtd (TSE:4886) Is Due To Pay A Dividend Of ¥27.00
Jul 10Weak Statutory Earnings May Not Tell The Whole Story For ASKA Pharmaceutical HoldingsLtd (TSE:4886)
May 21ASKA Pharmaceutical HoldingsLtd (TSE:4886) Is Due To Pay A Dividend Of ¥25.00
Mar 13ASKA Pharmaceutical HoldingsLtd (TSE:4886) Has Announced A Dividend Of ¥25.00
Feb 27ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Dividend Will Be ¥25.00
Feb 08ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Profits May Not Reveal Underlying Issues
Nov 19ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals
May 21Shareholder Returns
| 4886 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.6% | -1.9% | 3.8% |
| 1Y | 11.0% | 18.0% | 35.5% |
Return vs Industry: 4886 underperformed the JP Pharmaceuticals industry which returned 18% over the past year.
Return vs Market: 4886 underperformed the JP Market which returned 35.5% over the past year.
Price Volatility
| 4886 volatility | |
|---|---|
| 4886 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 8.0% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4886 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4886's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1920 | 1,632 | Sohta Yamaguchi | www.aska-pharma-hd.co.jp |
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices.
ASKA Pharmaceutical Holdings Co.,Ltd. Fundamentals Summary
| 4886 fundamental statistics | |
|---|---|
| Market cap | JP¥60.60b |
| Earnings (TTM) | JP¥4.77b |
| Revenue (TTM) | JP¥67.02b |
Is 4886 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4886 income statement (TTM) | |
|---|---|
| Revenue | JP¥67.02b |
| Cost of Revenue | JP¥34.61b |
| Gross Profit | JP¥32.41b |
| Other Expenses | JP¥27.65b |
| Earnings | JP¥4.77b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 02, 2026
| Earnings per share (EPS) | 167.88 |
| Gross Margin | 48.36% |
| Net Profit Margin | 7.11% |
| Debt/Equity Ratio | 17.4% |
How did 4886 perform over the long term?
See historical performance and comparisonDividends
Does 4886 pay a reliable dividends?
See 4886 dividend history and benchmarks| ASKA Pharmaceutical HoldingsLtd dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 25 2026 |
| Days until Ex dividend | 71 days |
| Days until Dividend pay date | 158 days |
Does 4886 pay a reliable dividends?
See 4886 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/17 07:10 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ASKA Pharmaceutical Holdings Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hidemaru Yamaguchi | Citigroup Inc |
| Seohyun Lee | Citigroup Inc |
| Yuriko Ishida | Mizuho Securities Co., Ltd. |